Advertisement

Topics

CytoReason Company Profile

08:31 EST 18th December 2018 | BioPortfolio

Born out of 10 years’ research from Stanford and the Technion, CytoReason is the only AI company to focus entirely on the immune system in developing its proprietary data and AI / machine-learning approach. This approach is capable of constructing 3-dimensional maps of previously hidden, immune-system relationships at a cellular, tissue and disease level. We call this the CytoReason Cell-Centered Model, and it is the key to unlocking immune system relational insights that can lead to biological discovery. Our cell-centered approach leverages public and proprietary data, proprietary technologies and methodologies, which when integrated with client data provides disease- and tissue-specific insights that can enhance discovery, shorten trial phases and reduce development costs.


News Articles [8 Associated News Articles listed on BioPortfolio]

CytoReason announces publication of new model for translating data from mouse models to human disease

CytoReason, developer of the world's first machine learning platform for human immune system cell-level simulation, today announces publication of a groundbreaking new model for translating data from ...

AI turns mice to men (and women) bridging drug development translation barrier

(CytoReason) CytoReason, developer of the world's first machine learning platform for human immune system cell-level simulation, today announces publication of a groundbreaking new model for translati...

Cytoreason’s Unique Immune-Focused AI Model Creates the Largest Library of Inter-Cellular ...

Read more...

CytoReason: New Machine-Learning Driven Findings Uncover New Cellular Players in Tumor Microenvironment That Might Point the Way to Improved Immunotherapy for Refractory Melanoma Patients

The results, presented at the American Association for Cancer Research Special AI Conference, identifies the potential involvement of adipocytes in nivolumab (anti-PD1) response i...

New findings reveal potential cellular players in tumor microenvironment

New findings presented today by CytoReason reveals possible new cellular players in the tumor microenvironment that could impact the treatment process for the most in-need patients - those who have al...

Cytoreason’s Unique Immune-Focused AI Model Creates the Largest Library of Inter-Cellular Communications - Uses It to Predict 335 Novel Cell-Cytokine Interactions, New Clues for Drug Development

New Data Published by Nature Biotechnology Covering 16,000,000 scientific articles, this massive Natural Language Processing (NLP) project quadruples the reference ...

New CytoReason Machine Learning Model Turns Mice into Men (and Women) to Overcome the Barrier of Cross-Species Differences in Drug Development, Published in Nature Methods

Groundbreaking model translates the results of new mouse experiments into the equivalent human condition, outperforming traditional methods of extrapolation by up to 50%. This cou...

Unique immune-focused AI model creates largest library of inter-cellular communications

(CytoReason) New data published in Nature Biotech, represents the largest ever analysis of immune cell signaling research, mapping more than 3,000 previously unlisted cellular interactions, and yieldi...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

CytoReason

Born out of 10 years’ research from Stanford and the Technion, CytoReason is the only AI company to focus entirely on the immune system in developing its proprietary data and...

More Information about "CytoReason" on BioPortfolio

We have published hundreds of CytoReason news stories on BioPortfolio along with dozens of CytoReason Clinical Trials and PubMed Articles about CytoReason for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CytoReason Companies in our database. You can also find out about relevant CytoReason Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record